Franklyn G. Prendergast - Sep 9, 2022 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role: Director
Signature: /s/ Dietrich A. Stephan, as attorney-in-fact for Franklyn G. Prendergast
Stock symbol: NBSE
Transactions as of: Sep 9, 2022
Transactions value $: $0
Form type: 4
Date filed: 9/12/2022, 05:01 PM
Previous filing: Jun 21, 2022
Next filing: Jun 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NBSE	Stock option (right to buy)	Award	$0	+37.6K		$0.00	37.6K	Sep 9, 2022	Common Stock	37.6K	$0.60	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the total shares shall vest on the first anniversary of September 9, 2022, and the remaining shares shall vest on an equal monthly basis over the following 36 months.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.